[HTML][HTML] Chitosan: a potential biopolymer in drug delivery and biomedical applications
Chitosan, a biocompatible and biodegradable polysaccharide derived from chitin, has
surfaced as a material of promise for drug delivery and biomedical applications. Different …
surfaced as a material of promise for drug delivery and biomedical applications. Different …
[HTML][HTML] Chitosan-based nanoparticles as effective drug delivery systems—a review
K Jafernik, A Ładniak, E Blicharska, K Czarnek… - Molecules, 2023 - mdpi.com
Chitosan-based nanoparticles (chitosan-based nanocomposites; chitosan nanoparticles;
ChNPs) are promising materials that are receiving a lot of attention in the last decades …
ChNPs) are promising materials that are receiving a lot of attention in the last decades …
Advances in preparation, biomedical, and pharmaceutical applications of chitosan-based gold, silver, and magnetic nanoparticles: a review
M Jiang, RH Althomali, SA Ansari, EAM Saleh… - International Journal of …, 2023 - Elsevier
During the last decades, the ever-increasing incidence of various diseases, like cancer, has
led to a high rate of death worldwide. On the other hand, conventional modalities (such as …
led to a high rate of death worldwide. On the other hand, conventional modalities (such as …
Emerging applications of anti-angiogenic nanomaterials in oncotherapy
B Tang, W Ma, Y Lin - Journal of Controlled Release, 2023 - Elsevier
Angiogenesis is the process of generating new blood vessels from pre-existing vasculature.
Under normal conditions, this process is delicately controlled by pro-angiogenic and anti …
Under normal conditions, this process is delicately controlled by pro-angiogenic and anti …
Smart chitosan-PLGA nanocarriers functionalized with surface folic acid ligands against lung cancer cells
A Narmani, S Ganji, M Amirishoar, R Jahedi… - International Journal of …, 2023 - Elsevier
Lung cancer is the second most prevalent and first killer cancer worldwide, and conventional
approaches do not have enough ability to suppress it. Therefore, a novel targeted chitosan …
approaches do not have enough ability to suppress it. Therefore, a novel targeted chitosan …
pH Sensitive Quercetin Nanoparticles Ameliorate DSS‐Induced Colitis in Mice by Colon‐Specific Delivery
L Wang, R Fu, Y Meng, J Liang, W Xue… - Molecular Nutrition & …, 2024 - Wiley Online Library
Scope Ulcerative colitis (UC) is a classic inflammatory bowel disease (IBD) that represents a
serious threat to human health. As a natural flavonoid with multiple biological activities …
serious threat to human health. As a natural flavonoid with multiple biological activities …
[HTML][HTML] Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures
This work aimed to develop and produce lacosamide-loaded niosomes coated with chitosan
(LCA-CTS-NSM) using a thin-film hydration method and the Box-Behnken design. The effect …
(LCA-CTS-NSM) using a thin-film hydration method and the Box-Behnken design. The effect …
Construction of multifunctional zinc ion sustained-release biocoating on the surface of carbon fiber reinforced polyetheretherketone with enhanced anti-inflammatory …
S Zhao, W Dong, Y Wang, X Zhou, J Jiang… - … Applied Materials & …, 2023 - ACS Publications
Current treatments of carbon fiber-reinforced polyetheretherketone (CFRPEEK) as
orthopedic implants remain unsatisfactory due to the bioinert surface. The …
orthopedic implants remain unsatisfactory due to the bioinert surface. The …
[HTML][HTML] Intranasal nanotransferosomal gel for quercetin brain targeting: I. Optimization, characterization, brain localization, and cytotoxic studies
Numerous neurological disorders have a pathophysiology that involves an increase in free
radical production in the brain. Quercetin (QER) is a nutraceutical compound that shields the …
radical production in the brain. Quercetin (QER) is a nutraceutical compound that shields the …
Repaglinide–Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box–Behnken Design, Characterization, and In Vivo Evaluation
Background Repaglinide (REP) is an antidiabetic drug with limited oral bioavailability
attributable to its low solubility and considerable first-pass hepatic breakdown. This study …
attributable to its low solubility and considerable first-pass hepatic breakdown. This study …